<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName journalpublishing.dtd?>
<?SourceDTD.Version 2.3?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-id journal-id-type="hwp">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">3394268</article-id>
    <article-id pub-id-type="pmid">22589414</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gks441</article-id>
    <article-id pub-id-type="publisher-id">gks441</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Articles</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>FTMAP: extended protein mapping with user-selected probe molecules</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Ngan</surname>
          <given-names>Chi Ho</given-names>
        </name>
        <xref ref-type="aff" rid="gks441-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bohnuud</surname>
          <given-names>Tanggis</given-names>
        </name>
        <xref ref-type="aff" rid="gks441-AFF1">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Mottarella</surname>
          <given-names>Scott E.</given-names>
        </name>
        <xref ref-type="aff" rid="gks441-AFF1">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Beglov</surname>
          <given-names>Dmitri</given-names>
        </name>
        <xref ref-type="aff" rid="gks441-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Villar</surname>
          <given-names>Elizabeth A.</given-names>
        </name>
        <xref ref-type="aff" rid="gks441-AFF1">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hall</surname>
          <given-names>David R.</given-names>
        </name>
        <xref ref-type="aff" rid="gks441-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kozakov</surname>
          <given-names>Dima</given-names>
        </name>
        <xref ref-type="aff" rid="gks441-AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="corresp" rid="gks441-COR1">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Vajda</surname>
          <given-names>Sandor</given-names>
        </name>
        <xref ref-type="aff" rid="gks441-AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="gks441-AFF1">
          <sup>2</sup>
        </xref>
        <xref ref-type="aff" rid="gks441-AFF1">
          <sup>3</sup>
        </xref>
        <xref ref-type="corresp" rid="gks441-COR2">*</xref>
      </contrib>
    </contrib-group>
    <aff id="gks441-AFF1"><sup>1</sup>Department of Biomedical Engineering, Boston University, 44 Cummington Street, <sup>2</sup>Bioinformatics Graduate Program, Boston University, 24 Cummington Street and <sup>3</sup>Department of Chemistry, Boston University, 590 Commonwealth Avenue, Boston, MA 02215, USA</aff>
    <author-notes>
      <corresp id="gks441-COR2">*To whom correspondence should be addressed. Tel: <phone>+1 617 353 4757</phone>; Fax: <fax>+1 617 353 6766</fax>; Email: <email>vajda@bu.edu</email></corresp>
      <corresp id="gks441-COR1">Correspondence may also be addressed to Dima Kozakov. Tel: <phone>+1 617 353 4842</phone>; Fax: <fax>+1 617 353 6766</fax>; Email: <email>midas@bu.edu</email></corresp>
      <fn>
        <p>The authors wish it be known that, in their opinion, the first two authors should be regarded as joint First Authors.</p>
      </fn>
    </author-notes>
    <!--For NAR both ppub and collection dates generated for PMC processing 1/27/05 beck-->
    <pub-date pub-type="collection">
      <month>7</month>
      <year>2012</year>
    </pub-date>
    <pub-date pub-type="ppub">
      <month>7</month>
      <year>2012</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>12</day>
      <month>6</month>
      <year>2012</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>12</day>
      <month>6</month>
      <year>2012</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
    <volume>40</volume>
    <issue>Web Server issue</issue>
    <fpage>W271</fpage>
    <lpage>W275</lpage>
    <history>
      <date date-type="received">
        <day>13</day>
        <month>3</month>
        <year>2012</year>
      </date>
      <date date-type="rev-recd">
        <day>24</day>
        <month>4</month>
        <year>2012</year>
      </date>
      <date date-type="accepted">
        <day>26</day>
        <month>4</month>
        <year>2012</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2012. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2012</copyright-year>
      <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
        <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <abstract>
      <p>Binding hot spots, protein sites with high-binding affinity, can be identified using X-ray crystallography or NMR by screening libraries of small organic molecules that tend to cluster at such regions. FTMAP, a direct computational analog of the experimental screening approaches, globally samples the surface of a target protein using small organic molecules as probes, finds favorable positions, clusters the conformations and ranks the clusters on the basis of the average energy. The regions that bind several probe clusters predict the binding hot spots, in good agreement with experimental results. Small molecules discovered by fragment-based approaches to drug design also bind at the hot spot regions. To identify such molecules and their most likely bound positions, we extend the functionality of FTMAP (<ext-link ext-link-type="uri" xlink:href="http://ftmap.bu.edu/param">http://ftmap.bu.edu/param</ext-link>) to accept any small molecule as an additional probe. In its updated form, FTMAP identifies the hot spots based on a standard set of probes, and for each additional probe shows representative structures of nearby low energy clusters. This approach helps to predict bound poses of the user-selected molecules, detects if a compound is not likely to bind in the hot spot region, and provides input for the design of larger ligands.</p>
    </abstract>
    <counts>
      <page-count count="5"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>INTRODUCTION</title>
    <p>Hot spots are locations on the protein surface that contribute significantly to the ligand binding free energy, and are important targets in many biological applications including rational drug design. The locations of these hot spots can be identified by screening a protein of interest against libraries of small organic molecules using NMR spectroscopy (<xref ref-type="bibr" rid="gks441-B1">1</xref>,<xref ref-type="bibr" rid="gks441-B2">2</xref>) or X-ray crystallography (<xref ref-type="bibr" rid="gks441-B3">3</xref>). The congregation of many types of small organic molecules in selected locations identifies the binding hot spots on the protein surface. The biophysical basis of this phenomenon is not fully understood, but many studies had substantiated this observation time and again (<xref ref-type="bibr" rid="gks441-B1 gks441-B2 gks441-B3">1–3</xref>). Fesik <italic>et al</italic>. (<xref ref-type="bibr" rid="gks441-B2">2</xref>) demonstrated the propensity of hot spots to bind many types of small organic molecules using NMR spectroscopy-based screening. The multiple solvent crystal structures (MSCS) method, based on X-ray crystallography, superimposes the structures of the target protein solved in 8–10 types of organic solutions to find clusters of small molecules (<xref ref-type="bibr" rid="gks441-B3">3</xref>).</p>
    <p>The identification of hot spots using biophysical methods such as NMR spectroscopy and MSCS is costly, time-consuming and is limited by physical constraints such as the solubility of the small organic molecules. FTMAP is a computational analog of these experimental approaches (<xref ref-type="bibr" rid="gks441-B4 gks441-B5 gks441-B6 gks441-B7 gks441-B8 gks441-B9">4–9</xref>). The method places molecular probes—small organic molecules that vary in size, shape and polarity—on a dense grid around the protein, and finds favorable positions using first an empirical energy function and then the CHARMM potential with a continuum electrostatics term. A number of low energy conformations are clustered and the clusters ranked on the basis of the average energy. The regions that bind several probe clusters are the predicted hot spots, and the one binding the largest number of probe clusters is considered the main hot spot. It was shown that FTMAP is capable of identifying the binding hot spots using a set of 16 small organic molecules as probes, in good agreement with the results of SAR by NMR and MSCS experiments (<xref ref-type="bibr" rid="gks441-B4">4</xref>). Aqueous solutions of most of these probes have also been used for soaking protein crystals in the MSCS experiments, which helps to directly compare the observed and predicted positions.</p>
    <p>The identification of hot spots plays an important role in fragment-based drug design (FBDD). FBDD generally starts with finding fragment-sized compounds that are highly ligand efficient and can serve as a core moiety for developing high-affinity leads. Such core moieties are most frequently found by soaking protein crystals in mixtures of compounds from a library of fragment-size molecules with functional groups that occur in known drugs. As recently shown, the core fragments always bind within the main hot spot identified by FTMAP. Additional secondary hot spots near the main hot spot show whether the core fragment can be extended and, if so, which directions are best for extension (<xref ref-type="bibr" rid="gks441-B9">9</xref>). These results have three important applications. First, the information helps to find the bound pose of potential cores, as such molecules always overlap with the main hot spot. In fact, it is frequently difficult to dock small molecules to proteins because they can fit into a number of pockets, in addition to the functional binding site, and current scoring functions provide limited accuracy for the elimination of false-positive positions. It was recently shown that searching for maximum correlation with the density of probes obtained by the mapping helps to locate the most likely poses of bound ligands. Second, if a small molecule has no docked position in the hot spot region then it is not likely to serve as a potential core. Third, the position and orientation of the fragment-sized molecules in the main and secondary hot spots provide input for the design of larger ligands that include several of the functional groups occurring in different fragments.</p>
    <p>In its earlier implementation, the FTMAP server could use only the pre-defined set of 16 molecules as probes (<xref ref-type="bibr" rid="gks441-B4">4</xref>). In view of the above discussion, it is of substantial interest to determine the distribution of bound poses for a variety of fragment-sized candidate molecules around the hot spots, i.e. adding such molecules to the standard probe set. Extending FTMAP to arbitrary probes we face two problems. First, the 16 molecules in our standard set have molecular weights below 100 and have no rotational degrees of freedom, whereas the libraries of fragment-sized compounds used for screening in FBDD usually consists of compounds with molecular weight in the range of 150–250 and with one or two rotatable bonds. Since the first stage of mapping is a rigid body global search, it is necessary to generate the set of the most likely rotamers. The extended FTMAP server accepts user-supplied small molecules as SMILES strings, and generates conformers using the program Confab (<xref ref-type="bibr" rid="gks441-B10">10</xref>) to be used alongside the 16 standard types of small molecules. Second, mapping needs a substantial number of parameters, both for the grid search and for the minimization by CHARMM. Parameters for the additional probes are generated by a variety of computational chemistry programs including ANTECHAMBER (<xref ref-type="bibr" rid="gks441-B11">11</xref>) based on the general AMBER force field (GAFF) (<xref ref-type="bibr" rid="gks441-B12">12</xref>), and General Atomic and Molecular and Electronic Structure Systems (GAMESS)(<xref ref-type="bibr" rid="gks441-B13">13</xref>). The charge model Austin Model 1 bond charge correction (AM1-BCC) (<xref ref-type="bibr" rid="gks441-B14">14</xref>) had been chosen to calculate atomic charges because the good quality of the charge assignments is similar to those computed using an <italic>ab initio</italic> scheme (<xref ref-type="bibr" rid="gks441-B15">15</xref>) but incurs much lower computational costs. The server can also be used for generating parameters only, i.e. without running an FTMAP analysis. The generated topology and parameter files can consequently be used in any application that requires CHARMM (<xref ref-type="bibr" rid="gks441-B16">16</xref>) file formats. The run time for mapping a protein is about 2 h when using only 16 types of probes, but can be longer if the user submits many additional molecules, or if the target protein is very large.</p>
  </sec>
  <sec sec-type="results">
    <title>RESULTS</title>
    <sec>
      <title>Protein mapping</title>
      <p>FTMAP globally samples the surface of a protein on a dense grid using 16 types of small molecules as probes (ethanol, isopropanol, isobutanol, acetone, acetaldehyde, dimethyl ether, cyclohexane, ethane, acetonitrile, urea, methylamine, phenol, benzaldehyde, benzene, acetamide and N,N-dimethylformamide). FTMAP performs four steps as follows (<xref ref-type="bibr" rid="gks441-B4">4</xref>).
<list list-type="roman-lower"><list-item><p>The rotational/translational space of each probe is systematically sampled on a grid around the fixed protein, consisting of 0.8 Å translations and of 500 rotations at each location. The energy function includes a stepwise approximation of the van der Waals energy with attractive and repulsive contributions, and an electrostatics/solvation term based on Poisson–Boltzmann continuum model (<xref ref-type="bibr" rid="gks441-B17">17</xref>) with the dielectric constants of ε = 4 and ε = 80 for the protein and the solvent, respectively. The 2000 best poses for each probe are retained for further processing.</p></list-item><list-item><p>The 2000 complexes are refined by off-grid energy minimization during which the protein atoms are held fixed while the atoms of the probe molecules are free to move. The energy function includes the bonded and van der Waals terms of the CHARMM potential and an electrostatics/solvation term based on the analytical continuum electrostatic (ACE) model as implemented in CHARMM (<xref ref-type="bibr" rid="gks441-B16">16</xref>).</p></list-item><list-item><p>The minimized probe conformations are grouped into clusters using a simple greedy algorithm and a 4 Å RMSD clustering radius. Clusters with &lt;10 members are excluded from consideration. The retained clusters are ranked on the basis of their Boltzmann averaged energies. Six clusters with the lowest average energies are retained for each probe.</p></list-item><list-item><p>To determine the hot spots, FTMAP finds consensus sites (CSs), i.e. regions on the protein where clusters of different probes overlap. Therefore, the probe clusters are clustered again using the distance between the centers of mass of the cluster centers as the distance measure and 4 Å as the clustering radius. The CSs are ranked based on the number of their clusters, with duplicate clusters of the same type also considered in the count. The largest CS defines the most important hot spot, with smaller CSs identifying secondary hot spots that generally also contribute to ligand binding.</p></list-item></list>
In this implementation, identical to the methodology used by Brenke <italic>et al</italic>. (<xref ref-type="bibr" rid="gks441-B4">4</xref>), the CSs are defined only by the clusters of the 16 probe types in the standard set, as these molecules provide reliable and stable hot spot information. The user-supplied small molecules are not used for hot spot identification, but the centers of the lowest energy clusters of these molecules within a radius of 4.0 Å from the center of the CSs are shown as additional results. For each conformer of each additional probe, the results online show only the lowest energy representative, but the top six lowest energy representatives can be found in the downloadable PyMol session. Some of the user-selected molecules may have no low energy clusters near any of the hot spots, which implies that they are not likely to bind in the hot spot region identified by FTMAP.</p>
    </sec>
    <sec>
      <title>Parameterization of small molecules for mapping</title>
      <p>The updated FTMAP server accepts user-supplied small molecules in the SMILES format. On the FTMAP main submission page, the user can either directly transfer the generated parameters to mapping, or download the files for inspection and editing and then upload them to be used in the mapping. The examples on the website provide step-by-step instructions. The user can also choose to generate topology and parameter files for the selected compounds in CHARMM file format without mapping any protein. The generation of parameters is based on a number of frequently used programs. The computational chemistry toolset RDKIT (RDKIT: Open-source chemoinformatics; <ext-link ext-link-type="uri" xlink:href="http://www.rdkit.org">http://www.rdkit.org</ext-link>) is used to generate 3D coordinates based on the submitted SMILES strings, and the program OpenBabel (<xref ref-type="bibr" rid="gks441-B18">18</xref>) performs all required chemical file format translations. The tool Confab (<xref ref-type="bibr" rid="gks441-B10">10</xref>) is then used to generate multiple conformations of the small molecules. Confab's methods utilize the MMFF94 force field to calculate the energy as it rotates single bonds between heavy atoms (excluding rings) if the contributing atoms connect to at least one additional heavy atom. The program then calculates the heavy atom RMSD to return only structures that differ by at least 0.5 Å. Due to computational limitations, only structures with fewer than 99 generated conformations (or about three rotatable bonds) are parameterized, but this constraint is generally not a problem when considering compounds used as potential starting points in FBDD.</p>
      <p>Subsequent to the generation of 3D coordinates, the quantum chemistry system GAMESS (<xref ref-type="bibr" rid="gks441-B18">18</xref>) is used to compute AM1 atomic charges; the information is then piped through molecule manipulation scripts from the Sarnoff Corporation (<ext-link ext-link-type="uri" xlink:href="http://charles.karney.info/b2d-scripts/">http://charles.karney.info/b2d-scripts/</ext-link>) using the molecular mechanics suite ANTECHAMBER (<xref ref-type="bibr" rid="gks441-B11">11</xref>) to perform BCCs and to generate the final AM1-BCC atomic charges. ANTECHAMBER generates GAFF-based (<xref ref-type="bibr" rid="gks441-B12">12</xref>) topology files and parameter files in the CHARMM (<xref ref-type="bibr" rid="gks441-B20">20</xref>) format. The GAFF (<xref ref-type="bibr" rid="gks441-B12">12</xref>) force field was constructed based on a number of sources, including parameters from the AMBER force field, crystal structures and <italic>ab initio</italic> optimizations (MP2/6-31G*) of nearly 2000 model molecules. Since the development of GAFF involved small organic compounds, the resulting parameters are generally transferable to a broad range of such compounds. GAFF is a complete force field, i.e. parameters are either available for all atom types or can be computed using empirical rules (<xref ref-type="bibr" rid="gks441-B12">12</xref>). Consequently, GAFF is capable of supplying parameters for most organic molecules of pharmaceutical significance composed of the atom types C, N, O, S, P, H and halogens, and is suitable for the modeling of molecules used in drug design.</p>
      <p>The calculation of partial charges using the AM1-BCC model consists of two steps. First, AM1 atomic charges are generated, followed by BCCs to obtain charges similar to the RESP (<xref ref-type="bibr" rid="gks441-B19">19</xref>) model. The general shortcoming of semi-empirical charge models is the poor transferability of parameters if the ligand of interest substantially differs from the molecules in the empirical data set used for constructing the parameters. To ensure transferability, Jakalian <italic>et al</italic>. (<xref ref-type="bibr" rid="gks441-B14">14</xref>) generated AM1 charges for 2755 molecules using MOPAC 6.0, and then computed BCC parameters by fitting against electrostatic potentials (ESPs) of these molecules, obtained by high-quality HF/6-31G* quantum mechanical calculations. The atom and bond types used to define these BCCs fully sample the atom and bond types from the Merck Index (10 000 molecules) and from the National Cancer Institute Database (250 000 molecules). Therefore, the AM1-BCC model can rapidly generate atomic charges of similar quality to the RESP (<xref ref-type="bibr" rid="gks441-B19">19</xref>) model for many small organic molecules. <xref ref-type="fig" rid="gks441-F1">Figure 1</xref>a shows the schematic diagram of the updated FTMAP server.
<fig id="gks441-F1" position="float"><label>Figure 1.</label><caption><p>Extended FTMAP server. (<bold>a</bold>) Schematic diagram of the updated implementation and the generation of force field parameters for user-supplied small molecules; programs used are indicated next to the appropriate boxes. (<bold>b</bold>) Mapping of an unbound structure of thrombin (PDB ID: 1HXF) using the small molecule C2A from a ligand-bound thrombin structure (PDB ID: 2C8Z) as a user-supplied additional probe. The lowest energy cluster of C2A (with the cluster shown as cyan sticks) overlaps the main consensus site (blue lines) from the mapping of the unbound thrombin structure using the standard probe set, and has an almost identical pose to the ligand from the bound structure (white sticks). Nitrogen and chlorine atoms are coloured blue and green, respectively.</p></caption><graphic xlink:href="gks441f1"/></fig></p>
    </sec>
    <sec>
      <title>Using the server</title>
      <p>The updated server is accessible online (<ext-link ext-link-type="uri" xlink:href="http://ftmap.bu.edu/param">http://ftmap.bu.edu/param</ext-link>) and has been tested using Google Chrome and Mozilla Firefox. The use of the server is free and open to all users, and there is no login requirement. Users can go through a test application under the ‘Examples’ tab for step-by-step instructions before submitting a job. The interface is minimalistic: as standard input, the user is required to supply either the PDB ID of the target protein or to upload a PDB coordinate file. The user also needs to enter the PDB chain ID to be used in the mapping. Following the input of the PDB ID (or uploading a PDB coordinate file) and chain identifiers, the user can choose either to use only the 16 small molecules for the mapping or to supplement the set with up to 10 additional molecules. These additional compounds are specified by their SMILES strings and formal charges (to the left of the SMILES strings). Isomeric SMILES must be used to specify the stereochemistry. The server generates conformers and compute physical parameters for each user-selected probe. If the user wants to inspect and edit the parameters of these compounds, then the SMILES strings should be submitted using the stand-alone parameterization function of the server by going to the ‘Parameterization’ tab. In addition, as described earlier, the parameterization server can be used to generate topology and parameter files in the CHARMM format, without submitting a protein to FTMAP for analysis.</p>
      <p>There are two restrictions on the use of our current FTMAP implementation. First, in order to limit computer time required for the mapping, the user can only submit SMILES strings of small molecules containing three or less rotatable bonds; typically this translates up to 100 conformers per compound. FTMAP is hosted on institutional computing facilities and because of the constraints on resources, excessively demanding computations are not feasible. Second, mapping proteins of 800 or more residues can sometimes fail because of similar constraints.</p>
    </sec>
    <sec sec-type="cases">
      <title>Case studies</title>
      <p>To demonstrate the function of the updated FTMAP server, we show the mapping of thrombin. Results are accessible on the FTMAP homepage under the ‘Examples’ tab by selecting ‘Sample Run’. The unbound structure of thrombin (PDB ID: 1HXF) (<xref ref-type="bibr" rid="gks441-B19">19</xref>) was mapped using the 16 standard probes and an additional small molecule (HETATM ID: C2A) used in an FBDD campaign and co-crystallized with thrombin (PDB ID: 2C8Z) (<xref ref-type="bibr" rid="gks441-B20">20</xref>). FTMAP identifies the important hot spots based on the consensus clusters of the 16 standard probes, and reports the lowest energy cluster representatives of C2A within 4 Å of each of the consensus cluster, using the geometric center distances in the calculations. <xref ref-type="fig" rid="gks441-F1">Figure 1</xref>b shows one of the lowest energy poses of C2A generated by computational mapping on top of the most populated consensus cluster. It is interesting to note that this pose is almost identical to the bound pose of C2A, co-crystallized with thrombin (PDB ID: 2C8Z). Although C2A is a weak binder with an IC<sub>50</sub> of only 300 µM, FTMAP was capable of detecting the interaction. The pose identified by computational mapping of C2A is particularly interesting, because the chlorophenyl group occupies the S1 site fully and the NH<sub>2</sub> group protrudes from the pocket, indicating the possibility of expanding the molecule. Indeed, C2A was subsequently joined with a 12 µM ligand to generate a 220 nM inhibitor (<xref ref-type="bibr" rid="gks441-B20">20</xref>). Therefore, in this case, computational mapping recapitulated important protein–ligand interactions, and this type of information can be very useful for screening candidate molecules in FBDD.</p>
      <p>Our earlier implementation of the FTMAP algorithm (<xref ref-type="bibr" rid="gks441-B4">4</xref>), using only the 16 standard probes, is still available at <ext-link ext-link-type="uri" xlink:href="http://ftmap.bu.edu/">http://ftmap.bu.edu/</ext-link>. Under the ‘Examples’ tab, the site shows mapping results for five additional proteins, angiotensin converting enzyme, carbonic anhydrase I, neuraminidase N2, phospholipase A2 and urokinase type plasminogen activator. An unbound structure, downloaded from the Protein Data Bank (<xref ref-type="bibr" rid="gks441-B21">21</xref>) was mapped for each protein. We have re-mapped the same structures (without any additional ligand) using the new server, and added the results under the ‘Examples’ tab. In each case, a ligand-bound form of the protein is aligned to the unbound form used in the computational mapping in order to show that the important CSs generally overlap with the positions of the bound ligands, and identify subsites of the ligand binding sites. Comparison of the results obtained by the two servers shows some differences, in spite of a qualitative agreement. Specifically, both the location and the ranking of the large hot spots remain unchanged for neuraminidase N2, phospholipase A2 and urokinase type plasminogen activator. For angiotensin converting enzyme, the second largest consensus cluster in the original FTMAP becomes the third one in the updated FTMAP results. For carbonic anhydrase I the second consensus cluster becomes the first (15 clusters in both cases), whereas the top consensus cluster becomes the third (17 clusters in the original and 13 in the updated results). These differences are primarily due to replacing the Poisson–Boltzmann equation solver of CHARMM (<xref ref-type="bibr" rid="gks441-B16">16</xref>), used in the earlier server, by the much faster APBS 1.3 program (<xref ref-type="bibr" rid="gks441-B22">22</xref>) in the calculation of the continuum electrostatics term. In addition, we perform the calculations in double precision. All other elements of the FTMAP algorithm remain unchanged.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions">
    <title>CONCLUSIONS</title>
    <p>The protein mapping algorithm FTMAP (<xref ref-type="bibr" rid="gks441-B4">4</xref>) is a computational analog of experimental screening approaches, based on NMR (<xref ref-type="bibr" rid="gks441-B1">1</xref>,<xref ref-type="bibr" rid="gks441-B2">2</xref>) or X-ray crystallography (<xref ref-type="bibr" rid="gks441-B3">3</xref>), to the identification of binding hot spots of proteins. The demonstrated robustness of mapping contrasts the uncertainty of finding bound poses of small ligands by traditional docking methods. FTMAP was originally implemented as a server that used only a standard set of 16 small molecules as probes. While this probe set is sufficient for the reliable identification of hot spots (<xref ref-type="bibr" rid="gks441-B4">4</xref>), it was shown that finding the distribution of further small molecules around the hot spot region can be very useful for FBDD (<xref ref-type="bibr" rid="gks441-B9">9</xref>). The extension of FTMAP described here enables the user to submit arbitrary small molecules for mapping. FTMAP identifies the hot spots using the standard probes, and for each additional probe provides representative poses of the lowest energy clusters located close to the hot spots. These results help to find bound poses for the user-specified molecules, show if a compound is not likely to bind in the hot spot region and provide input for the design of larger ligands (<xref ref-type="bibr" rid="gks441-B9">9</xref>).</p>
  </sec>
  <sec>
    <title>FUNDING</title>
    <p><funding-source>National Institute of General Medical Sciences</funding-source> [<award-id>GM064700</award-id>]. Funding for open access charge: <funding-source>National Institutes of Health</funding-source>.</p>
    <p><italic>Conflict of interest statement</italic>. None declared.</p>
  </sec>
</body>
<back>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="gks441-B1">
      <label>1</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liepinsh</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Otting</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Organic solvents identify specific ligand binding sites on protein surfaces</article-title>
        <source>Nat. Biotechnol.</source>
        <year>1997</year>
        <volume>15</volume>
        <fpage>264</fpage>
        <lpage>268</lpage>
        <pub-id pub-id-type="pmid">9062927</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B2">
      <label>2</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hajduk</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Huth</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Fesik</surname>
            <given-names>SW</given-names>
          </name>
        </person-group>
        <article-title>Druggability indices for protein targets derived from NMR-based screening data</article-title>
        <source>J. Med. Chem.</source>
        <year>2005</year>
        <volume>48</volume>
        <fpage>2518</fpage>
        <lpage>2525</lpage>
        <pub-id pub-id-type="pmid">15801841</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B3">
      <label>3</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mattos</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ringe</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Locating and characterizing binding sites on proteins</article-title>
        <source>Nat. Biotechnol.</source>
        <year>1996</year>
        <volume>14</volume>
        <fpage>595</fpage>
        <lpage>599</lpage>
        <pub-id pub-id-type="pmid">9630949</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B4">
      <label>4</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Brenke</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kozakov</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Chuang</surname>
            <given-names>GY</given-names>
          </name>
          <name>
            <surname>Beglov</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Landon</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Mattos</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Vajda</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Fragment-based identification of druggable ‘hot spots’ of proteins using Fourier domain correlation techniques</article-title>
        <source>Bioinformatics</source>
        <year>2009</year>
        <volume>25</volume>
        <fpage>621</fpage>
        <lpage>627</lpage>
        <pub-id pub-id-type="pmid">19176554</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B5">
      <label>5</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ngan</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Beglov</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Rudnitskaya</surname>
            <given-names>AN</given-names>
          </name>
          <name>
            <surname>Kozakov</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Waxman</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Vajda</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>The structural basis of pregnane X receptor binding promiscuity</article-title>
        <source>Biochemistry</source>
        <year>2009</year>
        <volume>48</volume>
        <fpage>11572</fpage>
        <lpage>11581</lpage>
        <pub-id pub-id-type="pmid">19856963</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B6">
      <label>6</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chuang</surname>
            <given-names>GY</given-names>
          </name>
          <name>
            <surname>Mehra-Chaudhary</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Ngan</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Zerbe</surname>
            <given-names>BS</given-names>
          </name>
          <name>
            <surname>Kozakov</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Vajda</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Beamer</surname>
            <given-names>LJ</given-names>
          </name>
        </person-group>
        <article-title>Domain motion and interdomain hot spots in a multidomain enzyme</article-title>
        <source>Protein Sci.</source>
        <year>2010</year>
        <volume>19</volume>
        <fpage>1662</fpage>
        <lpage>1672</lpage>
        <pub-id pub-id-type="pmid">20589904</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B7">
      <label>7</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kozakov</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Chuang</surname>
            <given-names>GY</given-names>
          </name>
          <name>
            <surname>Cencic</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Brenke</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Grove</surname>
            <given-names>LE</given-names>
          </name>
          <name>
            <surname>Beglov</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Pelletier</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Whitty</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Vajda</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Structural conservation of druggable hot spots in protein-protein interfaces</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2011</year>
        <volume>108</volume>
        <fpage>13528</fpage>
        <lpage>13533</lpage>
        <pub-id pub-id-type="pmid">21808046</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B8">
      <label>8</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ngan</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Zerbe</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Grove</surname>
            <given-names>LE</given-names>
          </name>
          <name>
            <surname>Kozakov</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Vajda</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>FTSite: high accuracy detection of ligand binding sites on unbound protein structures</article-title>
        <source>Bioinformatics</source>
        <year>2012</year>
        <volume>28</volume>
        <fpage>286</fpage>
        <lpage>287</lpage>
        <pub-id pub-id-type="pmid">22113084</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B9">
      <label>9</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hall</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Ngan</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Zerbe</surname>
            <given-names>BS</given-names>
          </name>
          <name>
            <surname>Kozakov</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Vajda</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Hot spot analysis for driving the development of hits into leads in fragment-based drug discovery</article-title>
        <source>J. Chem. Inf. Model.</source>
        <year>2012</year>
        <volume>52</volume>
        <fpage>199</fpage>
        <lpage>209</lpage>
        <pub-id pub-id-type="pmid">22145575</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B10">
      <label>10</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>O'Boyle</surname>
            <given-names>NM</given-names>
          </name>
          <name>
            <surname>Vandermeersch</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Flynn</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Maguire</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Hutchison</surname>
            <given-names>GR</given-names>
          </name>
        </person-group>
        <article-title>Confab: systematic generation of diverse low-energy conformers</article-title>
        <source>J. Cheminform.</source>
        <year>2011</year>
        <volume>3</volume>
        <fpage>8</fpage>
        <pub-id pub-id-type="pmid">21410983</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B11">
      <label>11</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Kollman</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Case</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <article-title>Automatic atom type and bond type perception in molecular mechanical calculations</article-title>
        <source>J. Mol. Graph. Model.</source>
        <year>2006</year>
        <volume>25</volume>
        <fpage>247</fpage>
        <lpage>260</lpage>
        <pub-id pub-id-type="pmid">16458552</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B12">
      <label>12</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wolf</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Caldwell</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Kollman</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Case</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <article-title>Development and testing of a general amber force field</article-title>
        <source>J. Comput. Chem.</source>
        <year>2004</year>
        <volume>25</volume>
        <fpage>1157</fpage>
        <lpage>1174</lpage>
        <pub-id pub-id-type="pmid">15116359</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B13">
      <label>13</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schmidt</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Baldridge</surname>
            <given-names>KK</given-names>
          </name>
          <name>
            <surname>Boatz</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Elbert</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>Gordon</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Koseki</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Matsunaga</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>SJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>General atomic and molecular electronic-structure system</article-title>
        <source>J. Comput. Chem.</source>
        <year>1993</year>
        <volume>14</volume>
        <fpage>1347</fpage>
        <lpage>1363</lpage>
      </element-citation>
    </ref>
    <ref id="gks441-B14">
      <label>14</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jakalian</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jack</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Bayly</surname>
            <given-names>CI</given-names>
          </name>
        </person-group>
        <article-title>Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation</article-title>
        <source>J. Comput. Chem.</source>
        <year>2002</year>
        <volume>23</volume>
        <fpage>1623</fpage>
        <lpage>1641</lpage>
        <pub-id pub-id-type="pmid">12395429</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B15">
      <label>15</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bayly</surname>
            <given-names>CI</given-names>
          </name>
          <name>
            <surname>Cieplak</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cornell</surname>
            <given-names>WD</given-names>
          </name>
          <name>
            <surname>Kollman</surname>
            <given-names>PA</given-names>
          </name>
        </person-group>
        <article-title>A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model</article-title>
        <source>J. Phys. Chem.</source>
        <year>1993</year>
        <volume>97</volume>
        <fpage>10269</fpage>
        <lpage>10280</lpage>
      </element-citation>
    </ref>
    <ref id="gks441-B16">
      <label>16</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Brooks</surname>
            <given-names>BR</given-names>
          </name>
          <name>
            <surname>Bruccoleri</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Olafson</surname>
            <given-names>BD</given-names>
          </name>
          <name>
            <surname>States</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Swaminathan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Karplus</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Charmm: a program for macromolecular energy, minimization, and dynamics calculations</article-title>
        <source>J. Comput. Chem.</source>
        <year>1983</year>
        <volume>4</volume>
        <fpage>187</fpage>
        <lpage>217</lpage>
      </element-citation>
    </ref>
    <ref id="gks441-B17">
      <label>17</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gilson</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Honig</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis</article-title>
        <source>Proteins</source>
        <year>1988</year>
        <volume>4</volume>
        <fpage>7</fpage>
        <lpage>18</lpage>
        <pub-id pub-id-type="pmid">3186692</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B18">
      <label>18</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Guha</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Howard</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Hutchison</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>Murray-Rust</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rzepa</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Steinbeck</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wegner</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Willighagen</surname>
            <given-names>EL</given-names>
          </name>
        </person-group>
        <article-title>The Blue Obelisk-interoperability in chemical informatics</article-title>
        <source>J. Chem. Inf. Model.</source>
        <year>2006</year>
        <volume>46</volume>
        <fpage>991</fpage>
        <lpage>998</lpage>
        <pub-id pub-id-type="pmid">16711717</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B19">
      <label>19</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Tulinsky</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>The molecular environment of the Na+ binding site of thrombin</article-title>
        <source>Biophys. Chem.</source>
        <year>1997</year>
        <volume>63</volume>
        <fpage>185</fpage>
        <lpage>200</lpage>
        <pub-id pub-id-type="pmid">9108691</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B20">
      <label>20</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Howard</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Abell</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Blakemore</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Chessari</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Congreve</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Howard</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jhoti</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Murray</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Seavers</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>van Montfort</surname>
            <given-names>RL</given-names>
          </name>
        </person-group>
        <article-title>Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitors</article-title>
        <source>J. Med. Chem.</source>
        <year>2006</year>
        <volume>49</volume>
        <fpage>1346</fpage>
        <lpage>1355</lpage>
        <pub-id pub-id-type="pmid">16480269</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B21">
      <label>21</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berman</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Westbrook</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gilliland</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bhat</surname>
            <given-names>TN</given-names>
          </name>
          <name>
            <surname>Weissig</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shindyalov</surname>
            <given-names>IN</given-names>
          </name>
          <name>
            <surname>Bourne</surname>
            <given-names>PE</given-names>
          </name>
        </person-group>
        <article-title>The Protein Data Bank</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2000</year>
        <volume>28</volume>
        <fpage>235</fpage>
        <lpage>242</lpage>
        <pub-id pub-id-type="pmid">10592235</pub-id>
      </element-citation>
    </ref>
    <ref id="gks441-B22">
      <label>22</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Baker</surname>
            <given-names>NA</given-names>
          </name>
          <name>
            <surname>Sept</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Joseph</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Holst</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>McCammon</surname>
            <given-names>JA</given-names>
          </name>
        </person-group>
        <article-title>Electrostatics of nanosystems: application to microtubules and the ribosome</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2001</year>
        <volume>98</volume>
        <fpage>10037</fpage>
        <lpage>10041</lpage>
        <pub-id pub-id-type="pmid">11517324</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
